Skip to main content

Table 3 Summary of participant characteristics

From: A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis

Reference

Dx

Sample (n)

Age (years, mean (SD)

Sex, female (%)

Illness duration

BMI (kg m−2), mean (SD)

Weight (kg), mean (SD)

CFS

HC

CFS

HC

CFS

HC

CFS

HC

CFS

HC

Armstrong et al.

Canadian (2003)

34

25

34.9 (1.8)

33.0 (1.6)

100%

100%

NR

24.0 (0.81)

23.0 (0.74)

NR

Frémont et al.

Fukuda (1994)

Belgian: 18

Norwegian: 17

Belgian: 19

Norwegian: 17

38.5 (13)

41 (12.5)

41 (12.6)

45 (19)

83%

88%

79%

82%

Belgian: 7 ± 4 years

Norwegian: 12 ± 9 years

NR

NR

Giloteaux et al.

Fukuda (1994)

49

39

50.2 (12.6)

45.5 (9.9)

78%

77%

NR

25.5 (4.9)

27.1 (6.1)

NR

Mandarano et al.

Fukuda (1994)

Taxa abundance comparisons 17

Diversity subgroup 11

Taxa abundance comparisons 17

Diversity subgroup 10

52 (11.9)

54 (11.6)

44.6 (10.9)

43.6 (13.6)

76%

64%

94%

90%

NR

26.8 (4.7)

26.2 (4.9)

27.4 (4.5)

27.7 (5.2)

NR

Rao et al.

Canadian (2003)

CFS placebo: 16

CFS treatment: 19

NR

77%

NR

NR

NR

Sheedy et al.

Holmes (1988) Fukuda (1994) Candain (2003)

108

177

NR

NR

NR

NR

NR

Shukla et al.

Fukuda (1994)

10

10

48.6 (10.5)

46.5 (13.0)

80%

80%

NR

23.9 (4.3)

24.6 (3.3)

68.3 (13.7)

65.5 (8.3)

  1. Dx diagnostic criteria, CFS/ME chronic fatigue syndrome/myalgic encephalomyelitis, HC healthy control, BMI body mass index, SD standard deviation, NR not reported